Richard O Mannion

Title: Richard O Mannion: Innovator in Pharmaceutical Formulations

Introduction

Richard O Mannion, a prominent inventor based in Furlong, PA, USA, has made significant contributions to the field of pharmaceuticals with an impressive portfolio of 40 patents. His work focuses primarily on innovative dosage forms that enhance the effectiveness and safety of pharmaceutical products.

Latest Patents

One of Richard Mannion's latest inventions includes a pharmaceutical dosage form characterized by a unique core-shell structure. This solid dosage form integrates two or more different active agents within a core that is encased by a shell. The core comprises a first matrix formulation containing at least one active agent, while the shell features a second matrix formulation. The weight ratio of these formulations ranges from about 1:10 to about 4:1. Notably, these oral solid extended-release dosage forms provide a delayed release of at least one active agent, catering to various patient needs.

Another significant patent involves tamper-resistant dosage forms that include opioid analgesics. This invention emphasizes the importance of safety in pharmaceutical applications, addressing the pressing concern of misuse and abuse of such medications. The development of these dosage forms reflects Richard's commitment to advancing both efficacy and patient safety in the pharmaceutical realm.

Career Highlights

Richard Mannion has had a distinguished career, working with notable companies such as Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. His experience in these organizations has played a pivotal role in shaping his innovative approach to pharmaceutical formulations.

Collaborations

Throughout his career, Richard has collaborated with esteemed colleagues, including William H. McKenna and Edward P. O'Donnell. These partnerships have further enhanced his research and development efforts, leading to the successful creation of various pharmaceutical innovations.

Conclusion

In conclusion, Richard O Mannion's extensive patent portfolio and innovative contributions to pharmaceutical dosage forms highlight his status as a leading inventor in his field. His work not only emphasizes the importance of effective drug delivery systems but also prioritizes patient safety through tamper-resistant formulations. As the pharmaceutical industry continues to evolve, Richard's innovations will undoubtedly play a significant role in shaping future developments.